- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05263726
The Effect of a Disease Self-management Program Through a Mobile Applications for Patients With Hypertension
March 22, 2023 updated by: Mei-Chen Lee, National Taipei University of Nursing and Health Sciences
Hypertension is a major cause of death worldwide.
Patients should adjust their lifestyle and learn how to maintain a balance between self-management of a disease and their daily livelihood.
Knowledge is networked, mobile devices can be used as a way of health education.
The purpose of this study is to evaluation the effectiveness of the disease self-management program through a mobile applications for patients with hypertension.
Statistical analyses was used analysis of covariance for checking the effect of interventions.
Through the calculation by a statistical power analysis formula, the study takes 70 samples and divides them into a control group (usual care) and an experimental group (disease self-management program through a mobile applications) by the single blind randomized controlled trial, whereby each groups has 35 samples.
The first step investigate the physiological indicators, mental health, self-management, quality of life of the patients.
For the experimental group, after the pre-test the study set up a health guide for the disease self-management program with a mobile applications.
The experimental group received the mobile apps educational program for at least 30 minutes each session and at least once every two days.
After two weeks and six weeks, a follow-up telephone interview helped to strengthen the health self-management self-confidence.
The effect of interventions was then evaluated after three months when the patients returned.
Therefore, the self-management of a disease can be improved and patients will learn to live in harmony with hypertension by improving their mental health, self-management, and quality of life.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Due to the aging population and the advancement of medical science and technology, people's lives have been extended longer in years, but at the same time the prevalence rate of chronic diseases is increasing.
Hypertension may cause several complications, resulting in abnormal organs either chronically or deadly.
Patients should adjust their lifestyle and learn how to maintain a balance between self-management of a disease and their daily livelihood.
Knowledge is networked, mobile devices can be used as a way of health education.
Therefore, this research builds a disease self-management program through a mobile applications that runs in accordance with expert validity, so as to effectively control hypertension and avoid its complications.
SPSS/Windows 22.0 helped with filing and statistical analyses, and analysis of covariance (ANCOVA) was used for checking the effect of interventions.
Through the calculation by a statistical power analysis formula, the study takes 70 samples and divides them into a control group (usual care) and an experimental group (disease self-management program through a mobile applications) by the single blind random control trial, whereby each groups has 35 subjects.
The first step tests the physiological indicators, mental health, self-management, and quality of life of the patients.
For the experimental group, after the pre-test the study set up a health guide for the disease self-management program with a mobile applications.
The experimental group received the mobile apps educational program for at least 30 minutes each session and at least once every two days.
After two weeks and six weeks, a follow-up telephone interview helped to strengthen the health self-management self-confidence.
The effect of interventions was then evaluated after three months when the patients returned.
The findings are expected to effectively control patients' hypertension in Taiwan after completing the research plan.
Therefore, the self-management of a disease can be improved and patients will learn to live in harmony with hypertension by improving their mental health, self-management, and quality of life.
Study Type
Interventional
Enrollment (Actual)
70
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
New Taipei City, Taiwan, 23148
- Cardinal Tien Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Clinical diagnosis of Hypertension Disease
- A clear state of consciousness and without diagnosis of mental illness
- Can communicate in Chinese and Taiwanese and are willing to participate in this study
- Age 18 years old the above
Exclusion Criteria:
- Cognitive dysfunction who are unable to understand the questionnaire
- Mental illness (severe depression, schizophrenia) reported in the medical records.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: DSMP through a mobile applications
This interventional divided the disease self-management program manual for patients with hypertension into 4 units, including: Unit 1: hypertension brief introduction and complications.
Unit 2: dietary precautions for patients with hypertension.
Unit 3: medication treatments for patients with hypertension.
Unit 4: the content included stress management (emotional control, spiritual support) of patients with hypertension.
The experimental group received the mobile apps educational program for at least 30 minutes each session and at least once every two days.
After two weeks and six weeks, a follow-up telephone interview helped to strengthen the health self-management self-confidence.
The researcher used the back office administration at the computer end to observe how the experimental group operated and used the mobile devices.
The effect of interventions was then evaluated after three months when the patients returned.
|
This interventional divided the disease self-management program manual for patients with hypertension into 4 units, including: Unit 1: hypertension brief introduction and complications.
Unit 2: dietary precautions for patients with hypertension.
Unit 3: medication treatments for patients with hypertension.
Unit 4: the content included stress management (emotional control, spiritual support) of patients with hypertension.
The experimental group received the mobile apps educational program for at least 30 minutes each session and at least once every two days.
After two weeks and six weeks, a follow-up telephone interview helped to strengthen the health self-management self-confidence.
The researcher used the back office administration at the computer end to observe how the experimental group operated and used the mobile devices.
The effect of interventions was then evaluated after three months when the patients returned.
|
|
No Intervention: Usual Care
Routine care
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Partner in Health Scale (PIH)
Time Frame: Change from Baseline Disease Self-management at 3 months.
|
This scale is a generic tool that was developed for measuring self-management knowledge and behaviors in patients with chronic illnesses (Battersby et al., 2003).
Original scale includes 11 items, contains five properties.
The internal consistency reliability Cronbach's α value of this scale is .88.
Then redefinition the six major principles of chronic condition self-management including disease knowledge, adherence to a treatment plan made in accordance with the healthcare provider, playing an active role in the decision-making process, awareness of warning symptoms and their management, coping with the effects the of the chronic illness in relation to the physical, mental and social aspects of life and practice of a healthy lifestyle.
The PIH scale is a self-report questionnaire that includes 12 items, which are answered using 9-point Likert-type scales (from 0 "very poor" to 8 "very well").
The total score ranges from 0 to 96, 0 representing poor self-management and 96 representing
|
Change from Baseline Disease Self-management at 3 months.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
World Health Organization-5 Well Being Index (WHO-5)
Time Frame: Change from Baseline Mental Health at 3 months.
|
This scale is a 5-item questionnaire.
The scoring included 0 point (at no time), representing the worst to 5 points (all of the time), representing the best.
The total score ranges from 0 to 25 points.
Patients whose total score is lower than 13 points or whose answer to any of the 5 items is 0 to 1 point are recommended to receive the test of severe depression scale or review a face-to-face interview with a psychologist to check whether they meet the medical diagnosis of depression.
The internal consistency reliability Cronbach's α value of this scale is .87.
The test-retest reliability of this scale in Germany and Japan is Cronbach's α .90
(Saipanish, Lotrakul, & Sumrithe, 2009).
The internal consistency reliability Cronbach's α value of this scale in Taiwan is Cronbach's α .89
(Lee et al., 2021)
|
Change from Baseline Mental Health at 3 months.
|
|
Medical Outcome Study Short Form-12 (MOS SF-12)
Time Frame: Change from Baseline quality of life at 3 months.
|
Both the SF-12 and SF-36 quality of life scales are derived from the Medical Outcomes Study (MOS).
SF-12 was finalized in 1994, with a total of 12 questions in two dimensions, PCS and MCS, which were four reverse questions (questions 1, 5, 6a, and 6b) that needed to be scored in reverse first.
As the measuring scale and scoring method of each question are different, it must be converted to the order of 0-100 points, where 100 points indicates the best condition.
The total score of all questions are divided by 12 to obtain the total score of the scale, which ranges from 0 to 120 points, the higher the score, the better the quality of life of the patients.
In 2021, Chen et al. (2021) used the SF-12 scale to measure patients with hypertensive nephropathy.
The results showed that the internal consistency Cronbach's α values of SF-12 were 0.88, 0.87, and 0.87, respectively, for the overall quality of life, quality of life in the PCS, and quality of life in the MCS.
|
Change from Baseline quality of life at 3 months.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Mei-Chen Lee, PhD, National Taipei University of Nursing and Health Sciences
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
- Text message-based lifestyle intervention in primary care patients with hypertension: A randomized controlled pilot trial.
- Mobile health applications for the management of primary hypertension: A multicenter, randomized, controlled trial.
- The effectiveness of electronic health interventions on blood pressure control, self-care behavioral outcomes and psychosocial well-being in patients with hypertension: A systematic review and meta-analysis.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 8, 2022
Primary Completion (Actual)
January 30, 2023
Study Completion (Actual)
January 30, 2023
Study Registration Dates
First Submitted
February 14, 2022
First Submitted That Met QC Criteria
February 27, 2022
First Posted (Actual)
March 3, 2022
Study Record Updates
Last Update Posted (Actual)
March 23, 2023
Last Update Submitted That Met QC Criteria
March 22, 2023
Last Verified
March 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CTH-109-3-1-062
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
Franz Rischard, DOAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...Not yet recruitingPulmonary Hypertension | Pulmonary Arterial Hypertension (PAH)United States
-
Abant Izzet Baysal UniversityNot yet recruitingPRIMARY HYPERTENSIONTurkey (Türkiye)
-
SingHealth PolyclinicsNanyang PolytechnicEnrolling by invitationHypertension,EssentialSingapore
-
Hacettepe UniversityBozok UniversityCompletedHypertension | Arterial Hypertension | Systemic HypertensionTurkey (Türkiye)
-
BackBeat Medical IncNot yet recruitingHypertension, Systolic | Hypertension (HTN) | Heart Failure With Preserved Ejection Fraction (HFpEFGeorgia
-
Xuanwu Hospital, BeijingNot yet recruiting
-
Shenzhen Salubris Pharmaceuticals Co., Ltd.Not yet recruiting
-
Instituto de Cardiologia do Rio Grande do SulCompletedHypertension (HTN) | Hypertension ArterialBrazil
Clinical Trials on DSMP through a Mobile Applications
-
Umm Al-Qura UniversityCompleted
-
ToDoMedCompleted
-
Rush University Medical CenterCompletedMental Health
-
Yu-Chien HuangCompletedCOVID-19 | Mental Health | Nurse | Cell Phone UseTaiwan
-
Kaohsiung Medical University Chung-Ho Memorial...Completed
-
Stanford UniversitySuspended
-
Loma Linda UniversityWithdrawnStroke | Cognitive Impairment | Cognitive Change | Executive Dysfunction | Cognitive DeficitUnited States
-
American University of Beirut Medical CenterRecruiting
-
Istanbul University - CerrahpasaThe Scientific and Technological Research Council of TurkeyCompletedAdolescent | Physical Activity | Childhood Rheumatic DiseaseTurkey (Türkiye)
-
Muhammed Onur HanedanCompleted